首页> 外国专利> Stabilized amorphous candesartan cilexetil compositions for oral administration

Stabilized amorphous candesartan cilexetil compositions for oral administration

机译:用于口服的稳定的无定形坎地沙坦西酯组合物

摘要

The present invention relates to stabilized amorphous candesartan cilexetil compositions for oral administration which have enhanced dissolution and reduced degradation characteristics, and to an efficient and economical process for the preparation of these compositions. Another aspect of the invention relates to stabilized amorphous candesartan cilexetil compositions, obtainable by said process, as pharmaceutical formulations prepared while employing said stabilized amorphous candesartan cilexetil compositions. The stabilized amorphous candesartan cilexetil compositions according to the present invention have greatly improved chemical stability. Preferred drug formulations according to the present invention are tablets, capsules, pellets, and granules prepared with usual, pharmaceutically acceptable excipients in ways known per se. Particularly preferred according to the invention are tablets which rapidly release the active ingredient that are prepared by direct compression of the stabilized amorphous candesartan cilexetil compositions obtained according to the present invention.
机译:本发明涉及具有增强的溶解和降低的降解特性的用于口服的稳定的无定形坎地沙坦西酯组合物,并且涉及制备这些组合物的有效和经济的方法。本发明的另一方面涉及通过所述方法可获得的稳定的无定形坎地沙坦西酯组合物,其是在使用所述稳定的无定形坎地沙坦西酯组合物时制备的药物制剂。根据本发明的稳定的无定形坎地沙坦西酯组合物具有大大改善的化学稳定性。根据本发明的优选药物制剂是用通常的药学上可接受的赋形剂以本身已知的方式制备的片剂,胶囊剂,丸剂和颗粒剂。根据本发明特别优选的是快速释放活性成分的片剂,其通过直接压制根据本发明获得的稳定的无定形坎地沙坦西酯组合物制备。

著录项

  • 公开/公告号EP1997479A1

    专利类型

  • 公开/公告日2008-12-03

    原文格式PDF

  • 申请/专利权人 HELM AG;

    申请/专利号EP20070010802

  • 申请日2007-05-31

  • 分类号A61K9/14;A61K9/16;A61K9/20;A61K31/4184;A61K9/28;A61K31/54;

  • 国家 EP

  • 入库时间 2022-08-21 19:19:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号